EIM
NEO icon

Essex Investment Management’s NeoGenomics NEO Stock Holding History

Essex Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-425,847
Closed -$1.7M – 375
2013
Q2 		$1.7M Buy
+425,847
New +$1.62M 0.3% 100

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Essex Investment Management's NEO Position: Q3 2013 in Review

Essex Investment Management sold out of NeoGenomics (NEO) in Q3 2013, closing a stake of 425,847 shares — an estimated $1.7M sold.

Essex Investment Management first reported a position in NEO in Q2 2013 and held it in 1 quarter. The position peaked at $1.7M in Q2 2013. 58 funds tracked by Wall St. Rank hold NEO as of Q3 2013.

  • Essex Investment Management reported no remaining NeoGenomics position as of Q3 2013 after selling out during the quarter.
  • Essex Investment Management sold 425,847 NeoGenomics shares in Q3 2013, an estimated $1.7M.
  • Essex Investment Management first reported a position in NeoGenomics in Q2 2013 and held it in 1 quarter.
  • Essex Investment Management's NeoGenomics position peaked at $1.7M in Q2 2013.
  • 58 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2013.

Based on Essex Investment Management's 13F filing for Q3 2013, filed 25 Oct 2013.